Purchase of Oncotype DX Tests
Estimated value
£392k
Awarded value
£392k
Awarded 31 Mar 2025
Suppliers
1
Lots
1
1 awarded
Published
27 May 2025
Deadline 30 Mar 2025
Description
Purchase of 290 Oncotype DX tests (145 per annum) Awarded to Exact Science via NHSSC - Laboratory Diagnostics, Point of Care Testing and Pathology Managed Service 2023/S 000-028831 Total cost = £391,500.00 Exc. VAT (£155,250.00 exc VAT per annum) Period - 01/04/2025 - 31/03/2027
Scope
- Reference
- C353309
- Total value
- £391,500 excluding VAT
- Commercial tool
- Standalone contract
- Contract dates
- 31 Mar 2025 to 30 Mar 2027
- CPV classifications
- 33698000
- Particular suitability
- Small and medium-sized enterprises (SME)
Submission & procedure
- Submission deadline
- 30 Mar 2025, 11:00 pm
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£392k
Award date
31 Mar 2025
Contract start
31 Mar 2025
Contract end
30 Mar 2027
Awarded to
Awarded suppliers· 1 supplier
Awarded 31 Mar 2025 · Contract period 31 Mar 2025 — 30 Mar 2027
Award value
£392k
Other contracts from Gateshead Health NHS Foundation Trust
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to EXACT SCIENCES· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Specialised Diagnostic testing for early invasive breast cancer patients | contract | — | 19 Mar 2026 |
| CALL OFF ORDER FOR ONCOTYPE DX TESTING | contract | — | 10 Mar 2026 |
| Oncotype DX Breast Cancer Testing | contract | £136k | 03 Mar 2026 |
| Exact Sciences - Oncotype DX Breast Recurrence Score tests | call off | £158k | 27 Feb 2026 |
| Send Away Test for Oncotype DX Breast Recurrence Score | contract | — | 03 Feb 2026 |
| Oncotype DX Breast recurrence score test | contract | £96k | 24 Oct 2025 |
| BTH25-027 Oncotype DX Breast Recurrence Score test | contract | £97k | 11 Apr 2025 |
| Specialised Diagnostic testing for early invasive breast cancer pat | contract | — | 17 Mar 2025 |
| Oncotype Testing | contract | — | 19 Jun 2024 |
| SUPPLY OF ONCOTYPE DX BREAST RECURRENCE SCORE TEST | contract | £304k | 03 May 2024 |